TCM
MDT icon

TD Capital Management’s Medtronic MDT Stock Holding History

TD Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Sell
493
-197
-29% -$15.9K ﹤0.01% 274
2026
Q1 		$59.8K Buy
690
+125
+22% +$12K 0.01% 220
2025
Q4 		$54.3K Buy
565
+410
+265% +$39.8K ﹤0.01% 224
2025
Q3 		$14.8K Hold
155
– – ﹤0.01% 373
2025
Q2 		$13.5K Buy
+155
New +$13.1K ﹤0.01% 377
2023
Q2 		– Sell
-78
Closed -$6.26K – 419
2023
Q1 		$6.26K Buy
78
+1
+1% +$82 ﹤0.01% 304
2022
Q4 		$5.98K Buy
+77
New +$6.24K ﹤0.01% 285

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

TD Capital Management's MDT Position: Q2 2026 in Review

TD Capital Management reduced its Medtronic (MDT) stake by 29% in Q2 2026, selling an estimated $15.9K and leaving 493 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #274.

TD Capital Management first reported a position in MDT in Q4 2022 and has held it in 7 quarters since. The position peaked at $59.8K in Q1 2026. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • TD Capital Management held 493 shares of Medtronic worth $38.6K as of Q2 2026.
  • TD Capital Management sold 197 Medtronic shares in Q2 2026, an estimated $15.9K.
  • Medtronic made up ﹤0.01% of TD Capital Management's portfolio in Q2 2026, its #274 holding.
  • TD Capital Management first reported a position in Medtronic in Q4 2022 and has held it in 7 quarters since.
  • TD Capital Management's Medtronic position peaked at $59.8K in Q1 2026.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.